News + Stories The Role of Stress Granules in ALS READ MORE Benefits of Using Cerebrospinal Fluid Samples in Medical Research READ MORE Target ALS and Alzheimer’s Drug Discovery Foundation Announce Award Recipients for Biomarker Research READ MORE The Effects of ALS on the Digestive System READ MORE How Upper and Lower Motor Neurons Relate to ALS READ MORE What Are The Most Common Symptoms of ALS? READ MORE ALS Genetic Mutations Explained READ MORE The Connection Between Dysphagia and ALS READ MORE Under the Microscope: Dr. Emanuele Buratti on the Role of TDP-43 in ALS Pathology READ MORE Target ALS Announces New Corporate Council Partnership Opportunity READ MORE ALS Muscle Twitching vs BFS Muscle Twitching: Knowing the Differences READ MORE Target ALS Issues Call For Proposals for ALS Biology-Focused Collaborative Projects READ MORE Leonard Florence Center for Living Offers Independence and Support for Individuals Living with ALS READ MORE Inaugural Rebecca Luker Courage Award of Recognition: Mark Calmes READ MORE Making Accessibility Accessible: John-boy’s Place and Windchime Wishes READ MORE Inaugural Rebecca Luker Courage Award of Recognition: Sandy Morris READ MORE Inaugural Rebecca Luker Courage Award of Recognition: Timothy Miller, MD/PhD READ MORE What is Bulbar-Onset ALS? Six Things to Know. READ MORE Inaugural Rebecca Luker Courage Award Unsung Hero Winner: Joumana Baroody READ MORE Winner of the Inaugural Rebecca Luker Courage Award: Merit E. Cudkowicz READ MORE n-Lorem Foundation and Columbia University Establish Silence ALS Initiative READ MORE Target ALS and Mitsubishi Tanabe Pharma America Announce Winner of the First Annual Rebecca Luker Courage Award READ MORE ALS in the Elderly: Recognizing ALS in Seniors READ MORE ALS and Nutrition: How Diet Impacts ALS Patients READ MORE Sporadic ALS: Understanding Why ALS Occurs with no Family History READ MORE How ALS Affects Speech READ MORE Saying Goodbye to a Friend Who Battled ALS: Julie Giacobassi READ MORE What Do We Talk About When We Talk About Genetics? READ MORE It’s Not Just Physical: ALS, Dementia, Cognitive Impairment and Memory Loss READ MORE Diagnosing ALS: It’s Often a Year-Long Journey READ MORE False Positives and False Negatives: How ALS Can be Misdiagnosed READ MORE How to Help Someone with ALS: Tips for Friends, Family members and Caregivers READ MORE How ALS Research Studies Work READ MORE ALS and Other Motor Neuron Diseases: What’s the Difference? READ MORE The Stages of ALS: Framing the Progression of a Nonlinear Disease READ MORE Alzheimer’s Drug Discovery Foundation (ADDF) and Target ALS Announce Partnership to Accelerate Biomarker Discovery and Development READ MORE Thinking About Participating in a Clinical Trial? Here’s What You Need to Know READ MORE Giving Back Hope: Creating Resources for Children Affected by ALS READ MORE Under the Microscope: Dr. Dan Elbaum on the Role of STATHMIN-2 READ MORE Reversing ALS? It’s Still Early, but ASO Therapeutics Are Generating Optimism READ MORE Baseball, the Father of Neurology and Epidemiology: Connecting the ALS Dots READ MORE Under the Microscope: Gene Yeo on RNA-Directed Therapy for ALS Caused by a C9ORF72 Mutation READ MORE Understanding ALS-Related Genes Leads to New ALS Therapeutic Insights READ MORE Complex Decisions: Predictive Genetic Testing for Family Members READ MORE Under the Microscope: Dr. Philip Wong on Searching for TDP-43 Biomarkers READ MORE Giving in the Face of ALS: A Fight to Help the ALS Community Keep Living After Diagnosis READ MORE Top 4 Things You Need to Know About ALS READ MORE How a Research Idea Transforms Into a Clinical Trial READ MORE Similarities in Neurodegenerative Disorders May Lead to New, Common Therapies READ MORE Tiny Protein, Enormous Potential: Why TDP-43 Matters READ MORE Target ALS and Mitsubishi Tanabe Pharma America Announce Rebecca Luker Courage Award Series and Call for Nominations READ MORE Target ALS Releases 2020 Annual Report READ MORE Under the Microscope: Christine Vande Velde on Seeking Solutions for Cellular Self Defense READ MORE Under the Microscope: Sami Barmada, M.D., Ph.D. on Biomarkers and Therapeutic Targets for ALS and FTD READ MORE Finding The Light Amidst ALS: Sunny Brous’ Story READ MORE The Power of Community + ALS: Bryan Rosica’s Story READ MORE To Dad, With Love: One Daughter’s Story of a Father’s ALS Journey READ MORE From an Arm Twitch To ALS Advocacy READ MORE Target ALS Announces “Becca,” a One-Night Only Streaming Concert Fundraiser Featuring Broadway’s Best-Known Stars, in Memory of Rebecca Luker READ MORE Target ALS Announces Second Round of 2020 Grant Recipients Focused on Discovering and Developing ALS Biomarkers READ MORE Target ALS Launches The First-Ever Comprehensive Research Initiative to Discover Urgently Needed ALS Biomarkers READ MORE Research Funding Decisions Made Fair; Independent Review is Key READ MORE We Salute You: Tom’s Life Was Defined By Much, But Not By ALS READ MORE Living Life to the Fullest: Eric’s Story of Giving ALS a Run for Its Money READ MORE Tripper’s Five Tips to Take on “The Toughest Challenge” in Support of ALS Research READ MORE ALS Charity Gets Creative During COVID-19 By Taking On ‘The Toughest Challenge’ READ MORE Under The Microscope: The Role of Genomics in ALS Research READ MORE Meet The Toughest Challenge For The Hardest Fight / Join Us to Make a Difference READ MORE 5 Answers About ALS From Our CEO READ MORE Our ROI: Impact to Date of the Target ALS Innovation Ecosystem READ MORE ‘The Unexpected Artist’: Guest Post by Ron Hoffman, Compassionate Care ALS Founder READ MORE ‘Never Say Invisible’: One Family’s Perspective on Living with ALS READ MORE UNDER THE MICROSCOPE: Why TDP-43 Matters So Much in ALS Research READ MORE Under the Microscope: Sophie Parmentier-Batteur on Interrogating a Protein Compound for Possible Therapeutic Approaches to ALS and FTD READ MORE UNDER THE MICROSCOPE: Ludo Van Den Bosch on Returning to Work, Exploring Therapeutic Strategies to Battle ALS & FTD READ MORE Searching for Information, a Media Resource Offers Credible, Compassionate News and Relatable Stories to the ALS Community READ MORE Under the Microscope: Fen-Biao Gao ofUMass Medical School Explains His Now-Funded Project Targeting Biomarkers and Disease Modifiers for ALS and FTD READ MORE Building a Safer Future: How Matt’s Place Foundation is Helping ALS Patients With Home Accessibility READ MORE Target ALS and AFTD Announce $5MM in Grants for Research Targeting Treatments and Biomarkers READ MORE Target ALS and The ALS Association Announce New TDP-43-Focused Biomarker Initiative READ MORE Target ALS Annual Meeting Canceled Due to the Spread of COVID-19 READ MORE Target ALS Expands Stem Cell Core to Include Innovative New Reporter Lines READ MORE What’s Next for Target ALS? A Preview of Our Work in 2020 READ MORE Thanks to Your Support: $35 Million Raised in 2019 READ MORE Target ALS Innovation Ecosystem Impact & Upcoming Initiatives READ MORE ALS/FTD Response Signals Resounding Desire for Collaboration READ MORE A Cancer Drug for ALS? Organization Forges Promising ALS Treatment, an Innovative Approach to Incubate Novel Therapeutics READ MORE NEWS: Target ALS-Funded Research Shows Promise in Slowing ALS Disease Progression Scientists Discover Method to Decrease Neuroinflammation and Extend Life Expectancy READ MORE 150 Years Later, Still No Effective Treatment for ALS. New Research Model Offers Hope READ MORE NEWS: Target ALS Biosample Recipients Identify Three Distinct Subtypes of ALS READ MORE Target ALS & AFTD Announce Groundbreaking Partnership to Spur Drug and Biomarker Development for ALS and FTD READ MORE The Boston Globe Features Target ALS Founder, Dan Doctoroff READ MORE Target ALS Awards Six Innovative Research Teams with Additional Target Discovery Funds READ MORE American Academy of Neurology and Target ALS Partner to Accelerate ALS Research READ MORE Case Study: Collaboration Accelerates Potential ALS Treatment READ MORE Case Study: Consortium Explores KPT-350 as a Potential Treatment for ALS READ MORE Target ALS Foundation Makes Human Stem Cell Lines Accessible to Researchers READ MORE Target ALS Providing Critical Tool to Study C9ORF72 Biology READ MORE Case Study: Biomarkers Offer Optimism for People with ALS READ MORE New Biomarker Study with Academic, Industry and Philanthropic Partners READ MORE Target ALS expands core facilities access to MDA development grant awardees READ MORE Target ALS Foundation Selects RUCDR Infinite Biologics READ MORE Partnership to Uncover Connection Between Ancient Retroviruses and ALS READ MORE Biogen and Target ALS Foundation Announce $20 Million Funding Challenge READ MORE The New York Times Features Daniel L. Doctoroff, Target ALS Founder READ MORE
